
✰PREMIUM
Breakthrough drug nearly doubles survival with advanced pancreatic cancer. An oncologist explains how daraxonrasib overcame an ‘undruggable’ disease
Should daraxonrasib succeed, it could help set the stage for more precise, personalized and effective treatments for pancreatic cancer.


































